Insider · CIK 0001601521

De Rubertis Francesco

Reports to the SEC for 3 companies · CHESHIRE

sec.gov

Transactions

Companies

Filings

CIK

0001601521

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Director	DDisposition to Issuer	−93.5K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Director	DDisposition to Issuer	−281K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Director	DDisposition to Issuer	−11.2M sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Director	DDisposition to Issuer	−4.4M sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Director	DDisposition to Issuer	−55.7K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Director	DDisposition to Issuer	−3.94M sh	—	—	0
2022-03-21	Centessa Pharmaceuticals plcJ Other	Director	JOther	+1.79M sh	—	—	11,197,303
2022-03-21	Centessa Pharmaceuticals plcJ Other	Director	JOther	+45.1K sh	—	—	281,162
2021-12-02	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+33.5K sh	$12.82	+$430K	3,936,970
2021-12-02	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+796 sh	$12.82	+$10.2K	93,526
2021-12-01	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+1,399 sh	$12.62	+$17.7K	92,730
2021-12-01	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+58.9K sh	$12.62	+$743K	3,903,440
2021-11-30	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+36K sh	$11.62	+$418K	3,844,535
2021-11-30	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+855 sh	$11.62	+$9,935.1	91,331
2021-11-29	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+55.4K sh	$11.70	+$648K	3,808,543
2021-11-29	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+1,315 sh	$11.70	+$15.4K	90,476
2021-11-26	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+274 sh	$11.34	+$3,105.872	89,161
2021-11-26	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+11.5K sh	$11.34	+$131K	3,753,152
2021-06-02	Centessa Pharmaceuticals plcSeries A Preferred SharesC Conversion	Director	CConversion	−44.8K sh	—	—	0
2021-06-02	Centessa Pharmaceuticals plcC Conversion	Director	CConversion	+1.89M sh	—	—	3,155,532
2021-06-02	Centessa Pharmaceuticals plcC Conversion	Director	CConversion	+44.8K sh	—	—	74,964
2021-06-02	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+586K sh	$20.00	+$11.7M	3,741,609
2021-06-02	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+13.9K sh	$20.00	+$278K	88,887
2021-06-02	Centessa Pharmaceuticals plcSeries A Preferred SharesC Conversion	Director	CConversion	−1.89M sh	—	—	0
2021-01-29	Centessa Pharmaceuticals plcSeries A Preferred SharesA Award	Director	AAward	+1.89M sh	$11.00	+$20.8M	1,886,990
2021-01-29	Centessa Pharmaceuticals plcSeries A Preferred SharesA Award	Director	AAward	+44.8K sh	$11.00	+$493K	44,828
2016-12-12	NERVMinerva Neurosciences, Inc. · Warrant SharesX Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−203K sh	—	—	0
2016-12-12	NERVMinerva Neurosciences, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+203K sh	$5.77	+$1.17M	4,690,906
2016-08-10	NERVMinerva Neurosciences, Inc.S Sale	Director, 10% Owner	SSale	−1M sh	$10.00	−$10M	4,488,272
2015-03-18	NERVMinerva Neurosciences, Inc. · Warrant SharesP Purchase	Director, 10% Owner	PPurchase	+203K sh	$0.13	+$25.3K	202,634
2015-03-18	NERVMinerva Neurosciences, Inc.P Purchase	Director, 10% Owner	PPurchase	+203K sh	$4.81	+$975K	5,488,272
2014-07-07	NERVMinerva Neurosciences, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.29M sh	$6.00	+$7.73M	4,952,305
2014-07-07	NERVMinerva Neurosciences, Inc.C Conversion	Director, 10% Owner	CConversion	+114K sh	$6.00	+$684K	3,602,883
2014-07-07	NERVMinerva Neurosciences, Inc.C Conversion	Director, 10% Owner	CConversion	+61.9K sh	$6.00	+$372K	3,664,805
2014-07-07	NERVMinerva Neurosciences, Inc. · Convertible Promissory NoteC Conversion	Director, 10% Owner	CConversion	−61.9K sh	$6.00	−$372K	0
2014-07-07	NERVMinerva Neurosciences, Inc.P Purchase	Director, 10% Owner	PPurchase	+333K sh	$6.00	+$2M	5,285,638
2014-07-07	NERVMinerva Neurosciences, Inc. · Convertible Promissory NoteC Conversion	Director, 10% Owner	CConversion	−114K sh	$6.00	−$684K	0
2014-03-20	Aravive, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000

Recent filings

Accepted (ET)
Jun 244
De Rubertis Francesco0001470831-26-000615
SEC(opens sec.gov)
Mar 234
De Rubertis Francesco0000899243-22-011941
SEC(opens sec.gov)
Dec 64
De Rubertis Francesco0000899243-21-046972
SEC(opens sec.gov)
Dec 24
De Rubertis Francesco0000899243-21-046599
SEC(opens sec.gov)
Nov 304
De Rubertis Francesco0000899243-21-046320
SEC(opens sec.gov)
Jun 44
De Rubertis Francesco0000899243-21-022071
SEC(opens sec.gov)

Companies

Address

C/O CENTESSA PHARMACEUTICALS PLC 3RD FLOOR, 1 ASHLEY RD, ALTRINCHAM

CHESHIRE, WA14 2DT